Connective Tissue Disorders and SIBO: EDS, Scleroderma, and the Gut
Ehlers-Danlos syndrome, scleroderma, and other connective tissue disorders directly affect gut structural integrity and motility. GI dysfunction is present in up to 75 percent of EDS patients.
Current Consensus
- Gastrointestinal involvement is present in up to 75 percent of Ehlers-Danlos syndrome patients.
- Scleroderma causes progressive fibrosis of GI smooth muscle and enteric nerves.
- The EDS-POTS-SIBO triad is increasingly recognized as a distinct clinical pattern.
- Joint hypermobility screening using the Beighton score can identify at-risk patients.
Open Questions
- Whether EDS-specific SIBO management protocols produce better outcomes than standard approaches.
- How to prevent progressive GI involvement in scleroderma patients with early-stage disease.
Not sure if this applies to you?
Our misdiagnosis quiz evaluates your symptoms against 14 conditions commonly confused with IBS.
Take the QuizArticles on Connective Tissue Disorders and IBS
Each article includes cited sources, a medical review placeholder, and a clear distinction between what is established and what is still being studied.
Ehlers-Danlos Syndrome and SIBO: The Connective Tissue Link to Gut Dysfunction
Up to 75% of EDS patients report GI symptoms. Learn how Ehlers-Danlos syndrome causes gut dysfunction through hypermobility, motility impairment, and ICC dysfunction, and why the EDS-POTS-SIBO triad is so common.
Hypermobility Screening for SIBO Patients: The Beighton Score and Beyond
Joint hypermobility is a common but overlooked root cause of SIBO. Learn the Beighton score, how to self-screen, when to seek formal evaluation, genetic testing options, managing EDS-associated SIBO, and POTS screening.
Scleroderma and the Gut: How Systemic Sclerosis Causes Chronic SIBO
Scleroderma affects the GI tract in up to 90% of patients, causing smooth muscle fibrosis, progressive dysmotility, and chronic SIBO. Learn about the pathology, esophageal involvement, treatment challenges, and management strategies.
Medical Disclaimer: The content in this section is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare professional before making changes to your health regimen. GLP1Gut is a tracking tool, not a medical device.